Clinical Trial Update: Neoadjuvant Study of Navelbine in Patients With HER2 Positive Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 neoadjuvant study evaluating Navelbine in HER2-positive breast cancer is ongoing; current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Navelbine (vinorelbine)

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Breast Cancer | Phase 3 | Status: UNKNOWN